DK1173187T3 - Kombinationspræparater indeholdende morpholinylanthracycliner og platinderivater - Google Patents

Kombinationspræparater indeholdende morpholinylanthracycliner og platinderivater

Info

Publication number
DK1173187T3
DK1173187T3 DK00925158T DK00925158T DK1173187T3 DK 1173187 T3 DK1173187 T3 DK 1173187T3 DK 00925158 T DK00925158 T DK 00925158T DK 00925158 T DK00925158 T DK 00925158T DK 1173187 T3 DK1173187 T3 DK 1173187T3
Authority
DK
Denmark
Prior art keywords
preparations containing
combination preparations
platinum derivatives
anthracyclines
morpholinyl anthracyclines
Prior art date
Application number
DK00925158T
Other languages
Danish (da)
English (en)
Inventor
Maria Cristina Geroni
Marina Ripamonti
Michele Caruso
Antonino Suarato
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Application granted granted Critical
Publication of DK1173187T3 publication Critical patent/DK1173187T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00925158T 1999-04-29 2000-04-04 Kombinationspræparater indeholdende morpholinylanthracycliner og platinderivater DK1173187T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909925.1A GB9909925D0 (en) 1999-04-29 1999-04-29 Combined preparations comprising anthracycline derivatives
PCT/EP2000/002923 WO2000066093A2 (en) 1999-04-29 2000-04-04 Combined preparations comprising morpholine anthracyclines and anticancer agent

Publications (1)

Publication Number Publication Date
DK1173187T3 true DK1173187T3 (da) 2003-10-20

Family

ID=10852508

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00925158T DK1173187T3 (da) 1999-04-29 2000-04-04 Kombinationspræparater indeholdende morpholinylanthracycliner og platinderivater

Country Status (16)

Country Link
US (2) US6537990B1 (de)
EP (3) EP1977753A1 (de)
JP (1) JP2002543112A (de)
CN (5) CN1535688A (de)
AR (1) AR023616A1 (de)
AT (2) ATE398457T1 (de)
AU (1) AU4397700A (de)
DE (2) DE60004348T2 (de)
DK (1) DK1173187T3 (de)
ES (2) ES2204572T3 (de)
GB (1) GB9909925D0 (de)
HK (1) HK1045462B (de)
MY (1) MY136610A (de)
PT (1) PT1173187E (de)
TW (1) TWI222863B (de)
WO (1) WO2000066093A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9916882D0 (en) * 1999-07-19 1999-09-22 Pharmacia & Upjohn Spa Antitumor synergistic composition
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
US20030133939A1 (en) 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
US7829084B2 (en) * 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
CA2440555A1 (en) * 2001-03-14 2002-09-19 Bristol-Myers Squibb Company Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
CA2383259A1 (en) 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
US20080075762A1 (en) * 2001-10-03 2008-03-27 Paul Tardi Compositions for delivery of drug combinations
JP4502641B2 (ja) * 2002-01-24 2010-07-14 ティルタン ファーマ リミテッド 抗癌組み合わせおよびその使用方法
TWI323662B (en) * 2002-11-15 2010-04-21 Telik Inc Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
US20060264388A1 (en) * 2003-02-26 2006-11-23 Olga Valota Method for treating liver cancer by intrahepatic administration of nemorubicin
EP1605951A1 (de) * 2003-03-18 2005-12-21 Pharmacia Italia S.p.A. Kombinationstherapie mit nemorubicin und einem cyclooxygenase-2-inhibitor
CN100500212C (zh) * 2005-04-06 2009-06-17 山东蓝金生物工程有限公司 一种抗实体肿瘤药物组合物
EP2295080A3 (de) * 2005-07-25 2011-06-22 Emergent Product Development Seattle, LLC B-Zell-Verringerung mit CD37-spezifischen und CD20-spezifischen Bindungsmolekülen
US7776832B2 (en) * 2006-04-21 2010-08-17 Gem Pharmaceuticals, Llc Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines
CN105837690A (zh) 2006-06-12 2016-08-10 新兴产品开发西雅图有限公司 具有效应功能的单链多价结合蛋白
US20090004134A1 (en) * 2006-09-08 2009-01-01 Obeid Michel Sarkis Kit for treating a health condition by inducing translocation of an erp57 protein to a cellular membrane
WO2008092796A1 (en) * 2007-01-29 2008-08-07 Nerviano Medical Sciences S.R.L. Antitumor combination comprising a morpholinyl anthracycline and an antibody
ES2552718T3 (es) 2007-05-11 2015-12-01 Nerviano Medical Sciences S.R.L. Composición farmacéutica de una antraciclina
JP2011513274A (ja) * 2008-02-26 2011-04-28 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ モルホリニルアントラサイクリン誘導体および脱メチル化剤を含む、抗腫瘍性組合せ
PT2132228E (pt) 2008-04-11 2011-10-11 Emergent Product Dev Seattle Imunoterapia de cd37 e sua combinação com um quimioterápico bifuncional
US8690833B2 (en) 2011-01-31 2014-04-08 Vascular Pathways, Inc. Intravenous catheter and insertion device with reduced blood spatter
JP6891118B2 (ja) 2014-12-23 2021-06-18 インテレクチュアル プロパティ アソシエイツ エルエルシーＩｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ａｓｓｏｃｉａｔｅｓ， ＬＬＣ 経皮投与のための方法及び製剤
KR102784293B1 (ko) 2015-09-21 2025-03-20 압테보 리서치 앤드 디벨롭먼트 엘엘씨 Cd3 결합 폴리펩타이드
US20190083386A1 (en) 2017-09-15 2019-03-21 Ampersand Biopharmaceuticals, Inc. Methods and formulations for transdermal administration of buffering agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710564A (en) * 1985-01-18 1987-12-01 Microbial Chemistry Research Foundation Anthracycline compounds
GB2172594B (en) 1985-03-22 1988-06-08 Erba Farmitalia New morpholino derivatives of daunorubicin and doxorubicin
US5902809A (en) * 1997-07-03 1999-05-11 Paracure, Inc. Arglabin compounds and therapeutic uses thereof
GB9806324D0 (en) 1998-03-24 1998-05-20 Pharmacia & Upjohn Spa Antitumour synergetic composition
GB9820012D0 (en) 1998-09-14 1998-11-04 Pharmacia & Upjohn Spa Use of an anthracycline derivative for the treatment of a liver tumor

Also Published As

Publication number Publication date
HK1045462A1 (en) 2002-11-29
CN1507869A (zh) 2004-06-30
AU4397700A (en) 2000-11-17
US20030087839A1 (en) 2003-05-08
CN1535688A (zh) 2004-10-13
DE60039260D1 (de) 2008-07-31
CN1853645A (zh) 2006-11-01
HK1045462B (zh) 2006-04-28
CN1349406A (zh) 2002-05-15
MY136610A (en) 2008-10-31
GB9909925D0 (en) 1999-06-30
EP1173187B1 (de) 2003-08-06
EP1323423B1 (de) 2008-06-18
US6537990B1 (en) 2003-03-25
TWI222863B (en) 2004-11-01
WO2000066093A2 (en) 2000-11-09
PT1173187E (pt) 2003-10-31
CN1853642A (zh) 2006-11-01
ATE246507T1 (de) 2003-08-15
ES2307867T3 (es) 2008-12-01
EP1977753A1 (de) 2008-10-08
ATE398457T1 (de) 2008-07-15
DE60004348D1 (de) 2003-09-11
JP2002543112A (ja) 2002-12-17
CN1222294C (zh) 2005-10-12
US6586428B2 (en) 2003-07-01
EP1173187A2 (de) 2002-01-23
EP1323423A1 (de) 2003-07-02
AR023616A1 (es) 2002-09-04
DE60004348T2 (de) 2004-02-26
WO2000066093A3 (en) 2001-01-25
ES2204572T3 (es) 2004-05-01

Similar Documents

Publication Publication Date Title
NO993868D0 (no) 3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
DK1112251T3 (da) Azetidinderivater, deres fremstilling og medikamenter indeholdende disse derivater
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
NO306401B1 (no) Oksazolidindionderivater, farmasöytisk preparat inneholdende slike derivater, og deres anvendelse
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
NO985368L (no) Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene
DK0871656T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
NO20005990D0 (no) Platinumkompleks, dets fremstilling og terapeutiske anvendelse
NO20003916L (no) Benzotiadiazoler og derivater
DK1057813T3 (da) Indolderivater og medicinske sammensætninger indeholdende de samme
NO20016247D0 (no) Streptograminderivater, deres fremstilling og preparater inneholdende derivatene
DK1025100T3 (da) 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf
NO20005919D0 (no) Platinakompleks, dets fremstilling og terapeutisk anvendelse
DK1066261T3 (da) Pyridinderivat og farmaceutisk præparat indeholdende samme
NO972256D0 (no) O-Benzyloksimeterderivater og deres anvendelse som pesticider
NO20024823D0 (no) Medisinske preparater inneholdende camptothecin-derivat og pH regulerende middel
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
NO972821D0 (no) 1-C-perfluoralkylglycosider, deres fremstilling og anvendelse